|
|
|||||||
|
Advertisement
|
Dilantin®
Clinical pharmacology of DilantinAbsorption When the chewable tablet form (Infatabs) of Dilantin is used, the peak level occurs more quickly, within about 1½ to 3 hours. The same time frame applies to the Dilantin-125 suspension. Phenytoin is also prepared in a parenteral form. The standard injectable phenytoin is slowly absorbed. A related drug, fosphenytoin (Cerebyx), is also given parenterally. It is rapidly converted to phenytoin in the body. With Cerebyx, therapeutic levels are achieved within 10 minutes and peak levels within 90 minutes. Some generic forms of phenytoin are now available in the United States. They may not be exactly equivalent to Dilantin pharmacologically. Distribution and metabolism At low concentrations, elimination is proportional to the concentration. But as the concentration rises to therapeutic levels, the enzyme system in the liver can become saturated and elimination occurs at a constant rate despite the dose (zero order kinetics). The effect is that a small increase in the dose sometimes causes a large change in the level of free phenytoin in the blood. Most phenytoin is excreted in the urine in the form of inactive metabolites. The half-life is about 22 hours, with a range of 7 to 42 hours. The half-life is shorter in children and longer in the elderly. Because phenytoin is metabolized in the liver, people with liver disease should be treated with caution. They may have to be started at a lower dose and have their dosage increased more slowly. Steady state |
||||||
|
© 2008 Epilepsy.com/professionals. All rights reserved.
Site Map |
Privacy Statement |
Terms of Use |
Problems? Email webmaster@epilepsytdp.org
|